The CDC is permanently ending all experiments on non-human primates at its facilities, marking the first time a major federal health agency has fully shut down its in-house monkey program. This pivotal shift is motivated by ethical concerns, the scientific ineffectiveness of primate research in translating to human treatments, and significant alarm over biosecurity failures. A key catalyst was the discovery of multiple tuberculosis cases in imported macaques, including instances where infected animals were released from quarantine and shipped to labs, creating a serious public health risk. The CDC’s move aligns with a wider federal trend to modernize research, including the FDA Modernization…

Newswire

Features

The Latest